相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Where does the toxicity come from in saponin extract?
Xiaogang Jiang et al.
CHEMOSPHERE (2018)
Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
Dante J. Marciani
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines
Samuel Cibulski et al.
VACCINE (2018)
Quillaja saponaria Saponins with Potential to Enhance the Effectiveness of Disinfection Processes in the Beverage Industry
Hubert Antolak et al.
APPLIED SCIENCES-BASEL (2018)
Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses
Samuel Paulo Cibulski et al.
SCIENTIFIC REPORTS (2018)
Performance of Quillaja bark saponin and β-lactoglobulin mixtures on emulsion formation and stability
Janaina Teles de Faria et al.
FOOD HYDROCOLLOIDS (2017)
Antimicrobial Effects of Quillaja saponaria Extract Against Escherichia coli O157:H7 and the Emerging Non-O157 Shiga Toxin-Producing E-coli
Snigdha Sewlikar et al.
JOURNAL OF FOOD SCIENCE (2017)
Quillaja saponaria bark saponin protects Wistar rats against ferrous sulphate-induced oxidative and inflammatory liver damage
Mustafa Ahmed Abdel-Reheim et al.
PHARMACEUTICAL BIOLOGY (2017)
Analysis of an immunoadjuvant saponin fraction from Quillaja brasiliensis leaves by electrospray ionization ion trap multiple-stage mass spectrometry
Federico Wallace et al.
PHYTOCHEMISTRY LETTERS (2017)
New perspectives for natural triterpene glycosides as potential adjuvants
Marie-Aleth Lacaille-Dubois et al.
PHYTOMEDICINE (2017)
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013
Christopher J. Genito et al.
VACCINE (2017)
A novel combination adjuvant platform for human and animal vaccines
Ravendra Garg et al.
VACCINE (2017)
Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer
Doris Lambracht-Washington et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
Iain Welsby et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia et al.
NPJ VACCINES (2017)
Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable
Danielle Poirier et al.
BIOMATERIALS (2017)
Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs
Viktor Ahlberg et al.
VETERINARY RESEARCH (2017)
Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
Robyn Marty-Roix et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice
Samuel Paulo Cibulski et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2016)
An Updated Review of ISCOMS™ and ISCOMATRIX™ Vaccines
Alexis Garcia et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica
Francheska Rivera et al.
EXPERIMENTAL PARASITOLOGY (2016)
Saponin Interactions with Model Membrane Systems Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs
Carolin de Groot et al.
PLANTA MEDICA (2016)
Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake
Samuel Paulo Cibulski et al.
VACCINE (2016)
Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)
John M. Dye et al.
VIRUSES-BASEL (2016)
Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing
Hwee-Ing Ng et al.
SCIENTIFIC REPORTS (2016)
A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
Roisin E. O'Cearbhaill et al.
CANCERS (2016)
Progress in natural emulsifiers for utilization in food emulsions
Bengu Ozturk et al.
CURRENT OPINION IN FOOD SCIENCE (2016)
Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge
Krishnamurthy Konduru et al.
PLOS ONE (2016)
Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
Sophie Detienne et al.
SCIENTIFIC REPORTS (2016)
Visualizing Compound Distribution during Zebrafish Embryo Development: The Effects of Lipophilicity and DMSO
Coco de Koning et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination
Geert Leroux-Roels et al.
VACCINE (2015)
Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol
Alberto Fernandez-Tejada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Protective effects of the total saponins from Dioscorea nipponica Makino against carbon tetrachloride-induced liver injury in mice through suppression of apoptosis and inflammation
Hao Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2014)
Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis
Maj-Linda B. Selenica et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Alternative Inactivated Poliovirus Vaccines Adjuvanted with Quillaja brasiliensis or Quil-A Saponins Are Equally Effective in Inducing Specific Immune Responses
Fernanda de Costa et al.
PLOS ONE (2014)
Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus)
Tharabenahalli-Nagaraju Vinay et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2014)
Surface activity of saponin from Quillaja bark at the air/water and oil/water interfaces
Kamil Wojciechowski
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: Stability and immunoefficiency studies
Ganesh Barhate et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
Wim H. J. Kruit et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy
Rachel Buglione-Corbett et al.
PLOS ONE (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci
Lee M. Krug et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Effects of Saponins against Clinical E. coli Strains and Eukaryotic Cell Line
Michal Arabski et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Anti-Trichomonas vaginalis activity of saponins from Quillaja, Passiflora, and Ilex species
Tabitha Dahmer Rocha et al.
PARASITOLOGY RESEARCH (2012)
Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
Jenny M. Reimer et al.
PLOS ONE (2012)
An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site
Fatima K. Ahmed et al.
VACCINE (2012)
Humoral and cellular immune responses in pigs immunized intranasally with crude rhoptry proteins of Toxoplasma gondii plus Quil-A
Ivo Alexandre Leme da Cunha et al.
VETERINARY PARASITOLOGY (2012)
Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina
Ka Ian Tam et al.
ANTIVIRAL RESEARCH (2011)
Stimulating Macrophage Activity in Mice and Humans by Oral Administration of Quillaja Saponin
Supaporn Naknukool et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2011)
ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells
Peter Duewell et al.
JOURNAL OF IMMUNOLOGY (2011)
Molecular activities, biosynthesis and evolution of triterpenoid saponins
Jorg M. Augustin et al.
PHYTOCHEMISTRY (2011)
Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN
Mohsen Tafaghodi et al.
PARASITOLOGY RESEARCH (2011)
Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit
Maliheh Mohaghegh et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2011)
Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation
F. Silveira et al.
VACCINE (2011)
Hemolytic and Antimicrobial Activities Differ Among Saponin-rich Extracts From Guar, Quillaja, Yucca, and Soybean
Sherif M. Hassan et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2010)
Fungal Growth Inhibition of Regenerated Cellulose Nanofibrous Membranes Containing Quillaja Saponin
Vivechana Dixit et al.
ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index
Hu
International Journal of Nanomedicine (2010)
Preparation and in vivo study of dry powder microspheres for nasal immunization
Mohsen Tafaghodi et al.
JOURNAL OF DRUG TARGETING (2010)
Effects of triterpenes on the immune system
Jose-Luis Rios
JOURNAL OF ETHNOPHARMACOLOGY (2010)
Saponins as cytotoxic agents: a review
Irma Podolak et al.
PHYTOCHEMISTRY REVIEWS (2010)
Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccine
Govind Ragupathi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
B Cells Are Essential for Moderating the Inflammatory Response and Controlling Bacterial Multiplication in a Mouse Model of Vaccination against Chlamydophila abortus Infection
Antonio J. Buendia et al.
INFECTION AND IMMUNITY (2009)
Feeding saponin-containing Yucca schidigera and Quillaja saponaria to decrease enteric methane production in dairy cows
L. Holtshausen et al.
JOURNAL OF DAIRY SCIENCE (2009)
The effect and mode of action of saponins on the microbial populations and fermentation in the rumen and ruminant production
A. K. Patra et al.
NUTRITION RESEARCH REVIEWS (2009)
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity
Balasubramanyam Karanam et al.
VACCINE (2009)
Synthesis of QS-21-xylose: Establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine
Kai Deng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs
Debra C. Quenelle et al.
ANTIVIRAL RESEARCH (2008)
Immune Responses of Mice with Different Genetic Backgrounds to Improved Multiepitope, Multitarget Malaria Vaccine Candidate Antigen FALVAC-1A
S. A. Kaba et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Protective effect of saponins derived from the roots of Platycodon grandiflorum against carbon tetrachloride induced hepatotoxicity in mice
Kyung Jin Lee et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Salim Abdulla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
Mahamadou A. Thera et al.
PLOS ONE (2008)
Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
Meta Roestenberg et al.
PLOS ONE (2008)
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial
Jahit Sacarlal et al.
VACCINE (2008)
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: Impact of distinct additional adjuvants
Katarina Radosevic et al.
VACCINE (2008)
Evaluation of ISCOMATRIX™ and ISCOM™ vaccines for immunisation against Helicobacter pylori
Caroline D. Skene et al.
VACCINE (2008)
Immunogenicity assay of the Leishmune® vaccine against canine visceral leishmaniasis in Brazil
G. P. Borja-Cabrera et al.
VACCINE (2008)
GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2007)
In vitro study of the antifungal activity of saponin-rich extracts against prevalent phytopathogenic fungi
Bishnu P. Chapagain et al.
INDUSTRIAL CROPS AND PRODUCTS (2007)
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults
Kent E. Kester et al.
VACCINE (2007)
Differences in the in vitro susceptibility of mono-eukaryotic cultures of Histomonas meleagridis, Tetratrichomonas gallinarum and Blastocystis sp. to natural organic compounds
Elvira Grabensteiner et al.
PARASITOLOGY RESEARCH (2007)
Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD
J. Lopez-Aban et al.
VETERINARY PARASITOLOGY (2007)
Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant
I. Mbawuike et al.
VACCINE (2007)
Safety trial using the Leishmune® vaccine against canine visceral leishmaniasis in Brazil
L. E. Parra et al.
VACCINE (2007)
Antiviral activity obtained from aqueous extracts of the Chilean soapbark tree (Quillaja saponaria Molina)
Michael R. Roner et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice
Juliane D. Fleck et al.
VACCINE (2006)
Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: Results of a phase I randomized trial
Mahamadou A. Thera et al.
PLOS CLINICAL TRIALS (2006)
Effects of Yucca schidigera and Quillaja saponaria extracts on in vitro ruminal fermentation and methane emission
B. Pen et al.
ANIMAL FEED SCIENCE AND TECHNOLOGY (2006)
Quillaja saponin can modulate ovalbumin-induced IgE allergic responses through regulation of Th1/Th2 balance in a murine model
Shigeru Katayama et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis
E. Oliveira-Freitas et al.
VACCINE (2006)
The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure
C Bachran et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2006)
Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1or HSV-2
DC Quenelle et al.
VACCINE (2006)
Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine
AD Cristillo et al.
VIROLOGY (2006)
Crude saponins improve the immune response to an oral plant-made measles vaccine
RJ Pickering et al.
VACCINE (2006)
On the preparation, microscopic investigation and application of ISCOMs
Julia Myschik et al.
MICRON (2006)
Degradation of Quillaja saponaria Molina saponins:: Loss of the protective effects of a herpes simplex virus 1 subunit vaccine (vol 2, pg 1703, 2002)
DJ Marciani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21
SF Slovin et al.
VACCINE (2005)
A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21:: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites
V Meraldi et al.
VACCINE (2005)
Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults
P Vandepapelière et al.
VACCINE (2005)
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP™703
KF Hu et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Adjuvants and antibody production: Dispelling the myths associated with Freund's complete and other adjuvants
HF Stills
ILAR JOURNAL (2005)
Constituents from leaves of Quillaja brasiliensis
C Kauffmann et al.
NATURAL PRODUCT RESEARCH (2004)
Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method
PH Demana et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin
LM Krug et al.
CLINICAL CANCER RESEARCH (2004)
Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes
PH Demana et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins
CBP de Sousa et al.
VACCINE (2004)
Metabolomic analysis of saponins in crude extracts of Quillaja saponaria by liquid chromatography/mass spectrometry for product authentication
GC Kite et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2004)
Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein
YAW Skeiky et al.
JOURNAL OF IMMUNOLOGY (2004)
Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine
GP Borja-Cabrera et al.
VACCINE (2004)
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection
M Regner et al.
MICROBES AND INFECTION (2004)
Biological activities and distribution of plant saponins
SG Sparg et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis
P Zhang et al.
VACCINE (2003)
Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis
MI de Jonge et al.
INFECTION AND IMMUNITY (2003)
Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria
NT Nyberg et al.
ANALYTICAL CHEMISTRY (2003)
Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates
KJ Stittelaar et al.
VACCINE (2002)
The biological action of saponins in animal systems: a review
G Francis et al.
BRITISH JOURNAL OF NUTRITION (2002)
Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)
GP Borj-Cabrera et al.
VACCINE (2002)
QS-21 structure/function studies: effect of acylation on adjuvant activity
G Liu et al.
VACCINE (2002)
Vaccination of donkeys against Babesia equi using killed merozoite immunogen
S Kumar et al.
VETERINARY PARASITOLOGY (2002)
Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins
DJ Marciani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Immune responses to ISCOM® formulations in animal and primate models
A Sjölander et al.
VACCINE (2001)
Immunization of metastatic breast cancer patients with a fully synthetic globe H conjugate: A phase I trial
T Gilewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans
TG Evans et al.
VACCINE (2001)
Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity
PN Boyaka et al.
JOURNAL OF IMMUNOLOGY (2001)
Antibody response in sheep following immunization with Streptococcus bovis in different adjuvants
Q Shu et al.
VETERINARY RESEARCH COMMUNICATIONS (2001)
Novel acetylated triterpenoid saponins in a chromatographic fraction from Quillaja saponaria Molina
LI Nord et al.
CARBOHYDRATE RESEARCH (2000)
Structural studies of triterpenoid saponins with new acyl components from Quillaja saponaria Molina
SJ Guo et al.
PHYTOCHEMISTRY (2000)
Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis
DPAJ da Fonseca et al.
VACCINE (2000)
Characterization of some O-acetylated saponins from Quillaja saponaria Molina
SJ Guo et al.
PHYTOCHEMISTRY (2000)
Hemolysis of human erythrocytes with saponin affects the membrane structure
E Baumann et al.
ACTA HISTOCHEMICA (2000)
Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants
K Oda et al.
BIOLOGICAL CHEMISTRY (2000)
分享论文
